Our combined GSEA results indicate that cholesterol metabolism and insulin resistance may regulate complex signaling pathways and antitumor immunity and play important roles in high CXCR4 expression DLBCL. The gene discussed is CXCR4; the disease is diffuse large B-cell lymphoma.